title: Human cytomegalovirus IE1 protein disrupts interleukin-6 signaling by sequestering STAT3 in the nucleus.
abstract: In the canonical STAT3 signaling pathway, binding of agonist to receptors activates Janus kinases that phosphorylate cytoplasmic STAT3 at tyrosine 705 (Y705). Phosphorylated STAT3 dimers accumulate in the nucleus and drive the expression of genes involved in inflammation, angiogenesis, invasion, and proliferation. Here, we demonstrate that human cytomegalovirus (HCMV) infection rapidly promotes nuclear localization of STAT3 in the absence of robust phosphorylation at Y705. Furthermore, infection disrupts interleukin-6 (IL-6)-induced phosphorylation of STAT3 and expression of a subset of IL-6-induced STAT3-regulated genes, including SOCS3. We show that the HCMV 72-kDa immediate-early 1 (IE1) protein associates with STAT3 and is necessary to localize STAT3 to the nucleus during infection. Furthermore, expression of IE1 is sufficient to disrupt IL-6-induced phosphorylation of STAT3, binding of STAT3 to the SOCS3 promoter, and SOCS3 gene expression. Finally, inhibition of STAT3 nuclear localization or STAT3 expression during infection is linked to diminished HCMV genome replication. Viral gene expression is also disrupted, with the greatest impact seen following viral DNA synthesis. Our study identifies IE1 as a new regulator of STAT3 intracellular localization and IL-6 signaling and points to an unanticipated role of STAT3 in HCMV infection.
authors.affiliation: Department of Microbiology and Molecular Genetics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
authors.forename: Justin M
authors.initials: JM
authors.lastname: Reitsma
authors.forename: Hiromi
authors.initials: H
authors.lastname: Sato
authors.forename: Michael
authors.initials: M
authors.lastname: Nevels
authors.forename: Scott S
authors.initials: SS
authors.lastname: Terhune
authors.forename: Christina
authors.initials: C
authors.lastname: Paulus
mesh_terms: D000818:Animals; D001254:Astrocytoma / Q000378:metabolism / Q000473:pathology / Q000821:virology; D015153:Blotting, Western; D002467:Cell Nucleus / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D003587:Cytomegalovirus / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000235:genetics / Q000378:metabolism / Q000821:virology*; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism / Q000821:virology; D005455:Fluorescent Antibody Technique; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics / Q000378:metabolism*; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D010766:Phosphorylation; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D015534:Trans-Activators; D014779:Virus Replication
chemical_list: C088645:IE1 protein, cytomegalovirus; D017874:Immediate-Early Proteins; D015850:Interleukin-6; D012333:RNA, Messenger; D050796:STAT3 Transcription Factor; D015534:Trans-Activators
references.citation: J Virol. 2009 May;83(9):4112-20
references.pmid: 19211736
references.citation: J Virol. 2001 Feb;75(4):1870-8
references.pmid: 11160686
references.citation: Nat Rev Immunol. 2006 Aug;6(8):602-12
references.pmid: 16868551
references.citation: BMC Cancer. 2011 Mar 28;11:112
references.pmid: 21443800
references.citation: Nucleic Acids Res. 1997 Jun 1;25(11):2062-7
references.pmid: 9153303
references.citation: J Virol. 2009 Oct;83(19):10187-97
references.pmid: 19625400
references.citation: Bioinformation. 2012;8(20):988-93
references.pmid: 23275693
references.citation: J Gen Virol. 1995 Sep;76 ( Pt 9):2151-60
references.pmid: 7561752
references.citation: Cell. 1995 Jul 28;82(2):241-50
references.pmid: 7543024
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3840-5
references.pmid: 16497831
references.citation: Eur J Cancer. 2010 Nov;46(16):2996-3006
references.pmid: 20709526
references.citation: J Virol. 2004 Sep;78(17):9084-92
references.pmid: 15308704
references.citation: Ann N Y Acad Sci. 2009 Aug;1171:59-76
references.pmid: 19723038
references.citation: J Antimicrob Chemother. 2009 May;63(5):862-7
references.pmid: 19287011
references.citation: Genes Dev. 2007 Jun 1;21(11):1396-408
references.pmid: 17510282
references.citation: Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84
references.pmid: 22006329
references.citation: J Biol Chem. 2012 Apr 20;287(17):14192-200
references.pmid: 22378781
references.citation: J Virol. 2010 Oct;84(20):10832-43
references.pmid: 20686030
references.citation: Cell Mol Life Sci. 2011 Mar;68(6):1079-90
references.pmid: 20803231
references.citation: J Virol. 2009 Dec;83(24):12854-70
references.pmid: 19812155
references.citation: J Virol. 2004 Jan;78(1):158-67
references.pmid: 14671097
references.citation: J Virol. 1989 Jun;63(6):2699-708
references.pmid: 2542583
references.citation: J Gen Virol. 1992 Mar;73 ( Pt 3):499-506
references.pmid: 1312114
references.citation: Exp Cell Res. 1996 Nov 25;229(1):155-8
references.pmid: 8940259
references.citation: Mol Interv. 2011 Feb;11(1):18-26
references.pmid: 21441118
references.citation: J Gen Virol. 2008 Feb;89(Pt 2):359-368
references.pmid: 18198366
references.citation: Intervirology. 1996;39(5-6):350-60
references.pmid: 9130045
references.citation: Nat Immunol. 2004 Apr;5(4):401-9
references.pmid: 15021879
references.citation: Pharmacol Rep. 2010 Mar-Apr;62(2):233-44
references.pmid: 20508278
references.citation: Nat Rev Cancer. 2009 Nov;9(11):798-809
references.pmid: 19851315
references.citation: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7391-6
references.pmid: 17463090
references.citation: J Gen Virol. 1998 May;79 ( Pt 5):1233-45
references.pmid: 9603339
references.citation: J Virol. 2008 Jul;82(13):6524-35
references.pmid: 18448536
references.citation: J Virol. 2008 Jul;82(14):7059-77
references.pmid: 18463148
references.citation: J Virol. 2002 Mar;76(5):2316-28
references.pmid: 11836410
references.citation: Nat Rev Immunol. 2007 Jan;7(1):41-51
references.pmid: 17186030
references.citation: J Gen Virol. 2008 Oct;89(Pt 10):2416-2426
references.pmid: 18796709
references.citation: Cell Host Microbe. 2011 Feb 17;9(2):103-14
references.pmid: 21320693
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11321-6
references.pmid: 8876134
references.citation: Curr Opin Infect Dis. 2011 Dec;24(6):605-11
references.pmid: 22001948
references.citation: Virus Res. 1994 Dec;34(3):191-206
references.pmid: 7856311
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8150-5
references.pmid: 15919823
references.citation: PLoS One. 2011;6(5):e20188
references.pmid: 21625522
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3141-6
references.pmid: 11867756
references.citation: J Virol. 2008 Nov;82(21):10444-54
references.pmid: 18701593
references.citation: Curr Opin Infect Dis. 2008 Aug;21(4):433-7
references.pmid: 18594298
references.citation: Clin Microbiol Rev. 2010 Oct;23(4):689-712
references.pmid: 20930070
references.citation: J Clin Invest. 2011 Oct;121(10):4043-55
references.pmid: 21946257
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):600-5
references.pmid: 22190485
references.citation: Sci Signal. 2010 Aug 03;3(133):ra58
references.pmid: 20682912
references.citation: Mol Cancer Ther. 2008 Nov;7(11):3519-26
references.pmid: 19001435
references.citation: EMBO J. 1999 Jun 1;18(11):3064-73
references.pmid: 10357818
references.citation: PLoS Pathog. 2010 Jun 24;6(6):e1000965
references.pmid: 20585571
references.citation: Cancer Res. 2007 Dec 1;67(23):11291-9
references.pmid: 18056455
references.citation: Virology. 1989 Oct;172(2):584-600
references.pmid: 2477948
references.citation: Chem Biol. 2006 Nov;13(11):1235-42
references.pmid: 17114005
references.citation: J Virol. 2003 Jun;77(11):6385-93
references.pmid: 12743296
references.citation: J Virol. 2011 Jan;85(2):663-74
references.pmid: 21047969
references.citation: Cell. 2002 Feb 8;108(3):331-44
references.pmid: 11853668
references.citation: Proc Natl Acad Sci U S A. 2010 May 4;107(18):8369-74
references.pmid: 20404187
references.citation: J Virol. 2004 Jun;78(12):6489-97
references.pmid: 15163742
references.citation: J Virol. 1992 Feb;66(2):1050-8
references.pmid: 1370547
references.citation: Acta Pharmacol Sin. 2012 May;33(5):682-90
references.pmid: 22504904
references.citation: PLoS Pathog. 2011 Apr;7(4):e1002016
references.pmid: 21533215
references.citation: PLoS Pathog. 2012;8(7):e1002789
references.pmid: 22792066
references.citation: J Virol. 1997 Jun;71(6):4599-613
references.pmid: 9151854
references.citation: J Biol Chem. 2009 Oct 9;284(41):28253-28262
references.pmid: 19679666
references.citation: Mol Cancer. 2010 Jun 25;9:165
references.pmid: 20576164
references.citation: J Virol. 1998 Jan;72(1):366-79
references.pmid: 9420235
references.citation: J Virol. 1991 Dec;65(12):6724-34
references.pmid: 1658371
references.citation: J Virol. 2007 Mar;81(5):2449-58
references.pmid: 17151100
references.citation: Eur J Cancer Prev. 2012 Sep;21(5):407-12
references.pmid: 22156994
references.citation: Cancer Res. 2005 Feb 1;65(3):939-47
references.pmid: 15705894
references.citation: PLoS Pathog. 2010 Jan 15;6(1):e1000721
references.pmid: 20084112
references.citation: J Virol. 2004 Jul;78(14):7803-12
references.pmid: 15220454